Takeda Pharmaceutical
TAK
#485
Rank
โ‚ฌ40.93 B
Marketcap
12,30ย โ‚ฌ
Share price
0.59%
Change (1 day)
-3.22%
Change (1 year)

Takeda Pharmaceutical (TAK) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : โ‚ฌ42.64 Billion

According to Takeda Pharmaceutical's latest financial reports the company's total liabilities are โ‚ฌ42.64 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Takeda Pharmaceutical - Total liabilities on balance sheet (from 2008 to 2025)

Total liabilities by year

Year Total liabilities Change
2025-03-31โ‚ฌ45.08 B-5.97%
2024-03-31โ‚ฌ47.94 B-8.65%
2023-03-31โ‚ฌ52.48 B-5.58%
2022-03-31โ‚ฌ55.59 B-6.64%
2021-03-31โ‚ฌ59.54 B-12.78%
2020-03-31โ‚ฌ68.27 B-1.18%
2019-03-31โ‚ฌ69.08 B332.95%
2018-03-31โ‚ฌ15.95 B-20.8%
2017-03-31โ‚ฌ20.14 B42.26%
2016-03-31โ‚ฌ14.16 B-12.66%
2015-03-31โ‚ฌ16.21 B13.66%
2014-03-31โ‚ฌ14.26 B0.48%
2013-03-31โ‚ฌ14.19 B9.12%
2012-03-31โ‚ฌ13.01 B136.36%
2011-03-31โ‚ฌ5.50 B6.57%
2010-03-31โ‚ฌ5.16 B-4.47%
2009-03-31โ‚ฌ5.40 B65.87%
2008-03-31โ‚ฌ3.25 B-16.25%
2007-03-31โ‚ฌ3.89 B-20.83%
2006-03-31โ‚ฌ4.91 B25.59%
2005-03-31โ‚ฌ3.91 B-9.47%
2004-03-31โ‚ฌ4.32 B12.16%
2003-03-31โ‚ฌ3.85 B-17.72%
2002-03-31โ‚ฌ4.68 B4.43%
2001-03-31โ‚ฌ4.48 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Johnson & Johnson
JNJ
โ‚ฌ97.64 B 128.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚ฌ56.78 B 33.16%๐Ÿ‡ซ๐Ÿ‡ท France
Pfizer
PFE
โ‚ฌ99.44 B 133.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚ฌ53.78 B 26.12%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Seagen
SGEN
โ‚ฌ0.93 B-97.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Dr. Reddy's Laboratories
RDY
โ‚ฌ1.74 B-95.92%๐Ÿ‡ฎ๐Ÿ‡ณ India
Amgen
AMGN
โ‚ฌ69.24 B 62.39%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
โ‚ฌ52.70 B 23.59%๐Ÿ‡ฌ๐Ÿ‡ง UK
Merck
MRK
โ‚ฌ66.76 B 56.57%๐Ÿ‡บ๐Ÿ‡ธ USA